Brief: Helius Announces Positive Outcome Of The Portable Neuromodulation Stimulator Pons Stroke Registrational Program

Solana

21/07/2025 12:07

July 21 (Reuters) - Helius Medical Technologies Inc HSDT.O:

HELIUS ANNOUNCES POSITIVE OUTCOME OF THE PORTABLE NEUROMODULATION STIMULATOR PONS® STROKE REGISTRATIONAL PROGRAM AND UPCOMING SUBMISSION TO FDA UNDER BREAKTHROUGH DESIGNATION

HELIUS MEDICAL TECHNOLOGIES INC - STUDIES CONFIRM MINIMAL ADVERSE EVENTS WITH PONS THERAPY

HELIUS MEDICAL TECHNOLOGIES: PLANNING TO FILE A SUBMISSION TO FDA FOR INDICATION IN STROKE DURING Q3 OF 2025

Source text: ID:nGNX4szG36

Further company coverage: HSDT.O

 ((Reuters.Briefs@thomsonreuters.com;))